- ... used in combination with tremelimumab-actl (Imjudo) and platinum-based chemotherapy to treat a certain type of NSCLC that ...
- ... Acupuncture to treat persistent CIPN from taxane or platinum-based chemotherapy Several studies have investigated the use of acupuncture ...
- ... for disease recurrence. Initial surgical resection followed by platinum-based chemotherapy. Diagnostic tumor biopsy and preoperative platinum-based chemotherapy ...
- ... that treatment for ovarian cancer, namely oophorectomy and platinum-based chemotherapy, may confer protection against subsequent breast cancer. In ... BRCA pathogenic variants had a better response to platinum-based chemotherapy, as measured by response to primary therapy, disease- ...
- ... Women who have a BRCA mutation, are receiving platinum-based chemotherapy for the first time, and are benefiting from ... are having a late recurrence and benefiting from platinum-based chemotherapy (platinum-sensitive relapse). Ovarian cancer is caused by ...
- ... to poly (ADP-ribose) polymerase (PARP) inhibition and platinum-based chemotherapy among males with metastatic, castrate-resistant prostate cancer ... PARP] inhibitors or immune checkpoint inhibitors), use of platinum-based chemotherapy, and sequencing of androgen-signaling therapy versus chemotherapy. ...
- ... C (FAM) or cisplatin (FAP). In the 1990s platinum based chemotherapy (cisplatin and carboplatin) was investigated more widely. From ... 3 Fluorouracil / anthracycline based chemotherapy. Table 23.4 Platinum based chemotherapy. Table 23.5 Platinum/Taxane based chemotherapy. Figure ...
- ... section of this summary for more information.) Chemotherapy Platinum-based chemotherapy is often used as first-line treatment for ... Vermorken JB, Mesia R, Rivera F, et al.: Platinum-based chemotherapy plus cetuximab in head and neck cancer. N ...
- ... serum LDH did not significantly affect response to platinum based chemotherapy , RR = 0.98 [0.68 to 1.41], ... more than twice as likely to respond to platinum based chemotherapy than patients with other histology . The relative risk ...
- ... 162 people were given pembrolizumab in combination with platinum-based chemotherapy (pemetrexed and either carboplatin or cisplatin), while 88 people had only platinum-based chemotherapy. Despite the advanced stage of the disease, all ...
44 results